Total Payments
$853.83
2024 Payments
$54.26
Companies
13
Transactions
49
Medicare Patients
149
Medicare Billing
$16,033
Payment Breakdown by Category
Food & Beverage$806.92 (94.5%)
Education$46.91 (5.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $806.92 | 48 | 94.5% |
| Education | $46.91 | 1 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $127.11 | 5 | $0 (2023) |
| Alkermes, Inc. | $118.09 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $114.76 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $105.86 | 12 | $0 (2022) |
| ABBVIE INC. | $90.30 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $77.24 | 4 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $64.96 | 4 | $0 (2022) |
| ITI, Inc. | $60.95 | 2 | $0 (2021) |
| Corium, LLC | $24.91 | 1 | $0 (2023) |
| Indivior Inc. | $19.74 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54.26 | 3 | Alkermes, Inc. ($23.48) |
| 2023 | $257.57 | 12 | Janssen Pharmaceuticals, Inc ($78.28) |
| 2022 | $224.81 | 13 | Neurocrine Biosciences, Inc. ($61.02) |
| 2021 | $317.19 | 21 | Sunovion Pharmaceuticals Inc. ($71.54) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Central Nervous System | ||||||
| 01/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: CNS | ||||||
| 12/12/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Neuroscience | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Neuroscience | ||||||
| 09/19/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/12/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: BH | ||||||
| 08/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Neuroscience | ||||||
| 06/20/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Central Nervous System | ||||||
| 03/22/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: CNS | ||||||
| 02/21/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/17/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Central Nervous System | ||||||
| 10/18/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Neuropsychiatry | ||||||
| 10/13/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: CNS | ||||||
| 09/23/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Neuropsychiatry | ||||||
| 09/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: CNS | ||||||
| 08/16/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CNS | ||||||
| 08/03/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Central Nervous System | ||||||
| 07/19/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: CNS | ||||||
| 06/16/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: CNS | ||||||
| 05/17/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 31 | 80 | $19,584 | $4,616 |
| 2022 | 2 | 38 | 55 | $18,652 | $3,608 |
| 2021 | 2 | 49 | 88 | $25,205 | $5,518 |
| 2020 | 1 | 31 | 47 | $17,294 | $2,291 |
Total Patients
149
Total Services
270
Medicare Billing
$16,033
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 67 | $16,402 | $4,079 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 13 | $3,182 | $537.18 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 38 | $9,302 | $2,018 | 21.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 17 | 17 | $9,350 | $1,590 | 17.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 25 | 58 | $14,198 | $3,249 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 18 | $4,406 | $1,194 | 27.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 11 | 12 | $6,600 | $1,075 | 16.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 35 | $12,905 | $1,682 | 13.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $4,389 | $609.06 | 13.9% |
About Jordan Wilson, PA-C
Jordan Wilson, PA-C is a Behavioral Neurology & Neuropsychiatry healthcare provider based in Raynham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1235651720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jordan Wilson, PA-C has received a total of $853.83 in payments from pharmaceutical and medical device companies, with $54.26 received in 2024. These payments were reported across 49 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($806.92).
As a Medicare-enrolled provider, Wilson has provided services to 149 Medicare beneficiaries, totaling 270 services with total Medicare billing of $16,033. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Behavioral Neurology & Neuropsychiatry
- Other Specialties Physician Assistant, Physician Assistant
- Location Raynham, MA
- Active Since 07/17/2017
- Last Updated 03/12/2025
- Taxonomy Code 2084B0040X
- Entity Type Individual
- NPI Number 1235651720
Products in Payments
- INVEGA SUSTENNA (Drug) $127.11
- LATUDA (Drug) $105.86
- VRAYLAR (Drug) $90.30
- ARISTADA (Drug) $78.02
- INGREZZA (Drug) $77.24
- AUSTEDO (Drug) $77.13
- CAPLYTA (Drug) $60.95
- REXULTI (Drug) $50.59
- LYBALVI (Drug) $40.07
- Austedo XR (Drug) $37.63
- ABILIFY MAINTENA (Drug) $29.61
- Azstarys (Drug) $24.91
- PERSERIS (Drug) $19.74
- TRINTELLIX (Drug) $18.42
- JORNAY PM (Drug) $16.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.